Propel Bio Management, LLC / CHRS
Propel Bio Management, LLC’s Coherus Oncology Inc Position
Does Propel Bio Management, LLC own Coherus Oncology Inc (CHRS)? Yes — 1.42M shares worth $2M (+1.52% of its 13F portfolio) as of Q1 2026.
Position Value
$2M
Q1 2026
Shares
1.42M
% of Portfolio
+1.52%
Quarters Held
1
currently held
Position History CHRS
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 1.42M | $2M | +1.52% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Propel Bio Management, LLC’s full portfolio or all institutional holders of CHRS.